SK Discovery launches bio strategy, investment division
The move will boost cooperation and synergy among the chemical company's bio affiliates
By Dec 06, 2022 (Gmt+09:00)
Samsung steps up AR race with advanced microdisplay for smart glasses


When in S. Korea, it’s a ritual: Foreigners make stops at CU, GS25, 7-Eleven


Maybe Happy Ending: A robot love story that rewrote Broadway playbook


NPS yet to schedule external manager selection; PE firms’ fundraising woes deepen


US auto parts tariffs take effect; Korea avoids heavy hit



Korea's chemical company SK Discovery Co. on Tuesday said it launched a bio strategy and investment division headed by Kim Jung-hoon, director of SK Chemicals' R&D center.
The new division will search for new business opportunities for SK Discovery's bio affiliates under the goal of creating horizontal expansion and a synergistic effect through inter-subsidiary collaboration.
A pharmaceutical and bio expert who joined SK Chemicals in 1998 after graduating from the College of Pharmacy at Seoul National University, Kim is experienced in leading overseas business, marketing and R&D organizations at the company.
"SK Discovery's bio affiliates have growth engines thanks to their outstanding human resources and business portfolios," Kim said. "The Bio Strategy and Investment Division will assume a role in fueling each affiliate's growth and creating a synergistic effect."
Write to Jeong Min Nam at peux@hankyung.com
-
Bio & PharmaSK Biopharma's epilepsy treatment posts impressive growth in US
Nov 11, 2022 (Gmt+09:00)
1 Min read -
COVID-19SK Bioscience seeks WHO nod for prompt COVID vaccine sale
Sep 08, 2022 (Gmt+09:00)
1 Min read -
Bio & PharmaSK Discovery to control affiliates’ entire biotechnology business
Aug 05, 2022 (Gmt+09:00)
2 Min read -
Corporate investmentSK takes aim at chips, batteries, bio with $195 billion investment
May 26, 2022 (Gmt+09:00)
3 Min read